Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Mercurius Praecipitatus Ruber
Brand Name
Mercurius Praecipitatus Ruber
Generic Name
Mercurius Praecipitatus Ruber
Active Ingredient
Mercuric OxideCategory
Standardized Insect Venom Allergenic Extract [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_C]/1 | PELLET | ORAL | 37662-3840 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-3847 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-3841 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Mercurius Praecipitatus Ruber, you must consult a qualified healthcare professional.
| 100 [hp_C]/1 | PELLET | ORAL | 37662-3843 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-3846 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-3844 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-3845 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-3842 |
Detailed information about Mercurius Praecipitatus Ruber
Mercuric Oxide is a specialized inorganic compound utilized as a standardized chemical allergen and historically as an antiseptic. It is classified under several EPCs, including Standardized Chemical Allergen and Corticosteroid Hormone Receptor Agonists.
Dosage for Mercuric Oxide is highly specialized and varies based on the clinical objective.
Mercuric Oxide is generally not recommended for pediatric use. Children are significantly more susceptible to the neurotoxic and renal effects of mercury. In rare cases where diagnostic patch testing is required for a child, it must be performed by a specialist (allergist or dermatologist) using the lowest possible concentration and the smallest surface area. There is no established safe dose for therapeutic Mercuric Oxide in children.
Because mercury is primarily excreted through the kidneys, patients with pre-existing renal disease (e.g., chronic kidney disease, glomerulonephritis) should avoid Mercuric Oxide. Even small amounts absorbed during diagnostic testing could theoretically exacerbate kidney dysfunction.
While the liver is not the primary site of Mercuric Oxide metabolism, significant hepatic impairment may alter the body's ability to handle oxidative stress caused by heavy metals. Use with caution and only if the diagnostic benefit outweighs the risk.
Elderly patients often have a natural decline in glomerular filtration rate (GFR). Consequently, they are at a higher risk for mercury accumulation. Dosage should be conservative, and monitoring for signs of systemic toxicity is essential.
Mercuric Oxide is for external use only. It must never be ingested or injected.
If you miss a dose of the ophthalmic ointment, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up. For diagnostic testing, if a patch falls off, contact your doctor immediately; do not attempt to re-apply it yourself.
Signs of acute topical overdose include severe skin irritation, blistering, or chemical burns at the site of application. Systemic overdose (mercury poisoning) symptoms include a metallic taste in the mouth, increased salivation, abdominal pain, bloody diarrhea, and kidney failure.
In case of accidental ingestion, seek emergency medical attention or contact a poison control center immediately. Treatment usually involves gastric lavage and the administration of chelating agents (such as Dimercaprol or Succimer) to bind the mercury and facilitate excretion.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or extend the duration of treatment without explicit medical guidance.
When used topically or in diagnostic testing, the most common side effects are localized to the site of application. These include:
Mercuric Oxide is a heavy metal compound that carries significant risks if misused. It should only be used under the direct supervision of a healthcare professional. Patients must be aware that mercury is a cumulative toxin, meaning it builds up in the body over time. Avoid applying Mercuric Oxide to open wounds, broken skin, or large areas of the body, as this significantly increases the risk of systemic poisoning.
No FDA black box warnings are currently issued for Mercuric Oxide; however, it is subject to the FDA's general policy regarding mercury-containing drug products for topical use. The FDA has stated that mercury compounds are not generally recognized as safe and effective (GRASE) for many OTC uses due to the potential for systemic absorption and toxicity.
Mercuric Oxide must NEVER be used in the following circumstances:
Mercuric Oxide is classified as FDA Pregnancy Category X (or equivalent in modern labeling) for therapeutic use. Mercury is a well-known teratogen (a substance that causes birth defects). It readily crosses the placenta and accumulates in fetal tissues, particularly the brain. Exposure during pregnancy can lead to 'fetal Minamata disease,' characterized by cerebral palsy, developmental delays, and microcephaly (small head size). Mercuric Oxide should never be used during pregnancy.
Inorganic mercury is excreted in human breast milk. Nursing infants are extremely sensitive to the neurotoxic effects of mercury, which can interfere with brain development and kidney function. If Mercuric Oxide must be used for a diagnostic procedure, breastfeeding should be discontinued for a period determined by a physician, or an alternative diagnostic method should be sought.
Mercuric Oxide is not approved for use in children. The risks of acrodynia (Pink Disease) and long-term neurodevelopmental issues far outweigh any potential therapeutic benefit. In the rare event of diagnostic patch testing in a child, it must be conducted with extreme caution by a pediatric allergy specialist.
Mercuric Oxide acts primarily as a protein-binding agent. The mercuric ion (Hg2+) has a high affinity for sulfhydryl (-SH) groups found on amino acids like cysteine. By binding to these groups, it inactivates essential enzymes and structural proteins within bacteria and fungi, providing its antiseptic effect. Its classification as a Corticosteroid Hormone Receptor Agonist stems from its ability to modulate local inflammatory pathways, potentially by inhibiting the release of pro-inflammatory cytokines or by inducing localized vasoconstriction, though this does not occur through the classical genomic glucocorticoid receptor pathway.
The onset of action for Mercuric Oxide's antiseptic effect is relatively rapid upon contact. However, its anti-inflammatory (corticosteroid-like) effects may take 24-48 hours to become apparent. The duration of effect is prolonged due to the stable binding of mercuric ions to tissue proteins. Tolerance does not typically develop, but the risk of toxicity increases linearly with the duration of use.
| Parameter | Value |
Common questions about Mercurius Praecipitatus Ruber
Mercuric Oxide is primarily used today as a standardized chemical allergen in patch testing to diagnose mercury allergies. Historically, the yellow form was widely used as a topical antiseptic ointment for treating eye infections like blepharitis and styes. It is also classified as a corticosteroid hormone receptor agonist in certain clinical contexts, reflecting its historical use in managing localized inflammation. Due to the risk of mercury toxicity, its therapeutic use has largely been replaced by safer modern alternatives. Always consult your doctor before using any product containing mercury.
The most common side effects of Mercuric Oxide are localized skin reactions, including redness, itching, and mild irritation at the site of application. When used in the eyes, it frequently causes temporary blurred vision due to the thick ointment base. Some patients may also experience eyelid swelling or a mild burning sensation. These effects are usually temporary and resolve once the medication is discontinued. If you notice persistent or severe skin blistering, contact your healthcare provider immediately.
While there is no known direct interaction between alcohol and Mercuric Oxide, it is generally advisable to exercise caution. Alcohol can stress the liver and kidneys, which are the organs responsible for processing and excreting any mercury that might be absorbed into your system. Chronic alcohol use may increase your vulnerability to heavy metal toxicity. For the duration of your treatment or diagnostic testing, it is best to limit alcohol consumption. Discuss your lifestyle habits with your doctor to ensure the safest possible outcome.
No, Mercuric Oxide is not considered safe during pregnancy and is generally contraindicated. Mercury is a potent neurotoxin that can cross the placenta and cause significant harm to the developing fetus, including brain damage and developmental delays. Even topical application carries a risk of systemic absorption that could affect the unborn child. If you are pregnant or planning to become pregnant, you must inform your doctor before undergoing any testing or treatment involving Mercuric Oxide. Safer alternatives are always preferred for pregnant patients.
The time it takes for Mercuric Oxide to work depends on its use. For antiseptic purposes in the eye, it begins working on contact, though visible improvement in symptoms may take 24 to 48 hours. In the context of diagnostic patch testing, it typically takes 48 to 72 hours for a hypersensitivity reaction to develop on the skin. Because it is a heavy metal compound, it remains in the tissues for a significant amount of time. If your symptoms do not improve within a few days of use, consult your healthcare provider.
Yes, you can typically stop using Mercuric Oxide suddenly, as it does not cause physical withdrawal symptoms like some other medications. In fact, if you suspect you are experiencing side effects or signs of mercury poisoning, you should stop use immediately. However, if you are using it to treat an infection, stopping too early may cause the infection to return. Always follow the specific duration of treatment prescribed by your doctor. If you are undergoing a patch test, do not remove the patch early without medical advice.
If you miss a dose of Mercuric Oxide ointment, apply it as soon as you remember. If it is nearly time for your next scheduled application, skip the missed dose and continue with your regular routine. Never apply a double dose to make up for a missed one, as this increases the risk of mercury accumulation and toxicity. For diagnostic patch tests, missing a 'dose' usually means a patch has fallen off; in this case, call your clinic immediately for instructions. Consistency is key to both effective treatment and accurate diagnostic results.
There is no clinical evidence to suggest that Mercuric Oxide causes weight gain. Unlike some systemic corticosteroids, which can cause fluid retention and metabolic changes leading to weight gain, Mercuric Oxide is used topically and in very small amounts. However, one sign of mercury-induced kidney damage (nephrotic syndrome) is significant swelling or edema in the legs and ankles, which might appear as a sudden increase in weight. If you notice rapid swelling or weight changes, seek medical attention immediately to check your kidney function.
Mercuric Oxide can interact with several other medications, most notably iodine-containing products, which can cause severe skin burns when combined. It may also interact with other topical ointments or systemic steroids. Because it is a heavy metal, it can interfere with certain enzymatic processes in the body if absorbed. It is vital to provide your doctor with a full list of all medications, including over-the-counter drugs and herbal supplements, before starting Mercuric Oxide. Your healthcare provider will check for potential incompatibilities to ensure your safety.
Mercuric Oxide is an inorganic compound and is not branded in the same way as modern pharmaceuticals; therefore, it is essentially available in its 'generic' chemical form. However, because its use has declined, it is rarely found as a mass-produced over-the-counter product in many countries. It is most commonly available through specialized medical suppliers for diagnostic use or through compounding pharmacies that can prepare specific ophthalmic or dermatological formulations. Availability may vary significantly by region and local pharmaceutical regulations.
> Warning: Stop using Mercuric Oxide and call your doctor immediately if you experience any of the following:
Prolonged exposure to Mercuric Oxide can lead to chronic mercury poisoning. This condition is characterized by a triad of symptoms: gingivitis (gum inflammation), tremors, and erethism (a psychological syndrome involving shyness, irritability, and depression). Chronic use can also lead to permanent kidney damage and peripheral neuropathy (numbness or tingling in the extremities). Because mercury accumulates in the body, the risk of these effects increases the longer the medication is used.
There are currently no standard FDA Black Box Warnings specifically for Mercuric Oxide as a standalone ingredient, largely because its use has been significantly curtailed in modern medicine. However, general warnings for mercury-containing products emphasize the risk of neurotoxicity and nephrotoxicity. Regulatory agencies warn that mercury-containing ointments should not be used over large body areas or for extended periods due to the risk of systemic absorption and subsequent heavy metal poisoning.
Report any unusual symptoms or side effects to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
If a patient is required to use Mercuric Oxide for more than a few days (which is rare in modern practice), the following monitoring is recommended:
Ophthalmic Mercuric Oxide will cause temporary blurred vision immediately after application. Patients should not drive, operate heavy machinery, or engage in any activity requiring clear vision until the ointment has cleared from the eye and vision is fully restored.
There is no direct pharmacokinetic interaction between alcohol and Mercuric Oxide. However, chronic alcohol consumption can impair liver and kidney function, potentially making the body more susceptible to the toxic effects of heavy metals. It is advisable to limit alcohol intake during any treatment involving mercury compounds.
Mercuric Oxide does not require a tapering period as it does not cause physiological dependence. However, if you are using it to treat an infection or inflammation and stop too early, the condition may return. Conversely, if you experience any signs of mercury toxicity (metallic taste, tremors, skin rash), you must discontinue use immediately and consult your doctor.
> Important: Discuss all your medical conditions, especially kidney or neurological disorders, with your healthcare provider before starting Mercuric Oxide.
For each major interaction, the mechanism typically involves either a direct chemical reaction (as with iodine) or a pharmacodynamic competition for protein binding sites. The clinical consequence is usually increased local tissue damage or systemic toxicity.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those applied to the skin or eyes.
Healthcare providers must perform a careful risk-benefit analysis in patients with:
Patients who react to Mercuric Oxide are likely to show cross-sensitivity to:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of heavy metal sensitivity, before prescribing or using Mercuric Oxide.
Older adults are at an increased risk for adverse effects from Mercuric Oxide due to age-related declines in kidney function. Mercury accumulation is more likely in this population, which can manifest as increased confusion, tremors, or renal impairment. Healthcare providers should monitor geriatric patients closely and use the shortest possible duration of treatment.
In patients with a GFR (Glomerular Filtration Rate) below 60 mL/min/1.73m², the use of Mercuric Oxide is generally avoided. If use is mandatory for diagnosis, frequent monitoring of serum creatinine and urinary protein is required. Mercury is not significantly cleared by hemodialysis or peritoneal dialysis; in fact, its presence can complicate the management of dialysis patients.
While the liver is not the primary organ for mercury excretion, patients with Child-Pugh Class B or C hepatic impairment may have altered protein binding and a reduced capacity to manage the systemic oxidative stress caused by heavy metal exposure. Use with extreme caution.
> Important: Special populations require individualized medical assessment and often require alternative, non-mercury-based treatments.
|---|---|
| Bioavailability | <5% (Intact Skin); >20% (Mucosa) |
| Protein Binding | >95% (Primarily Albumin) |
| Half-life | 30 - 60 days |
| Tmax | 2 - 4 hours (Topical) |
| Metabolism | Non-enzymatic (Redox reactions) |
| Excretion | Renal (approx. 70%), Fecal (approx. 30%) |
Mercuric Oxide belongs to the class of Inorganic Mercurials. Within its therapeutic area, it is related to other compounds such as Mercuric Chloride and Ammoniated Mercury. Under the EPC system, it is uniquely categorized as a Standardized Chemical Allergen and a Standardized Insect Venom Allergenic Extract, reflecting its specialized use in modern immunology and allergy diagnostics.